Invivyd, Inc. (IVVD)
1.435
-0.02
(-1.71%)
USD |
NASDAQ |
May 07, 16:00
1.435
0.00 (0.00%)
After-Hours: 20:00
Invivyd Research and Development Expense (Annual) : 38.31M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| MannKind Corp. | 66.35M |
| Viemed Healthcare, Inc. | 3.017M |
| Altimmune, Inc. | 66.32M |
| CorMedix, Inc. | 19.33M |
| Ocugen, Inc. | 37.36M |